A detailed history of Vital Stone Financial, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Vital Stone Financial, LLC holds 2 shares of MRNA stock, worth $131. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2
Previous 2 -0.0%
Holding current value
$131
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 15, 2023

SELL
$96.41 - $126.61 $6,748 - $8,862
-70 Reduced 97.22%
2 $0
Q2 2023

Aug 21, 2023

BUY
$118.5 - $160.53 $2,370 - $3,210
20 Added 38.46%
72 $11,000
Q1 2023

May 12, 2023

SELL
$135.66 - $197.02 $2,713 - $3,940
-20 Reduced 27.78%
52 $14,000
Q4 2022

Jan 30, 2023

BUY
$118.38 - $210.04 $8,523 - $15,122
72 New
72 $13 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $25.7B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Vital Stone Financial, LLC Portfolio

Follow Vital Stone Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vital Stone Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vital Stone Financial, LLC with notifications on news.